Response Biomedical Cleared for Rapid Respiratory Syncytial Virus Test
Response Biomedical Corp announces that it received a US FDA 510(k) clearance to market a rapid Respiratory Syncytial Virus (RSV) test.
Read MoreMonth: August 2009
DxS and AstraZeneca to Provide Companion Diagnostic for IRESSA
DxS Ltd announces it is working closely with AstraZeneca to make available a companion diagnostic for use with IRESSA (gefitinib), AstraZenecas treatment for non small cell lung cancer (NSCLC).
Read More